Co-investigator on GSBTM funded major research project titled “Therapeutic Targeting of Androgen Receptor as a biomarker to improve the clinical outcomes of Triple-Negative Breast Cancer” worth 44,14,856/-. (Project duration: 28/12/2021 to 27/12/2024).

Co-investigator on GSBTM funded major research project titled “Therapeutic Targeting of Androgen Receptor as a biomarker to improve the clinical outcomes of Triple-Negative Breast Cancer” worth 44,14,856/-.